These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11230887)

  • 21. Bronchoscopy-Guided Cooled Radiofrequency Ablation as a Novel Intervention Therapy for Peripheral Lung Cancer.
    Koizumi T; Tsushima K; Tanabe T; Agatsuma T; Yokoyama T; Ito M; Kanda S; Kobayashi T; Yasuo M
    Respiration; 2015; 90(1):47-55. PubMed ID: 26044954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Application of a Hybrid RapidArc Radiotherapy Technique for Locally Advanced Lung Cancer.
    Silva SR; Surucu M; Steber J; Harkenrider MM; Choi M
    Technol Cancer Res Treat; 2017 Apr; 16(2):224-230. PubMed ID: 27680023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External irradiation and intraluminal irradiation using middle-dose-rate iridium in patients with roentgenographically occult lung cancer.
    Fuwa N; Matsumoto A; Kamata M; Kodaira T; Furutani K; Ito Y
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):965-71. PubMed ID: 11240237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.
    Kim YS; Yoon SM; Choi EK; Yi BY; Kim JH; Ahn SD; Lee SW; Shin SS; Lee JS; Suh C; Kim SW; Kim DS; Kim WS; Park HJ; Park CI
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):76-81. PubMed ID: 15850905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Late course three-dimensional conformal radiotherapy in patients with stage III non-small cell lung cancer].
    Wang XC; Wang SY; Yang S; Ding Y; Shang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):726-8. PubMed ID: 15958322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.
    Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation.
    Wurstbauer K; Deutschmann H; Kranzinger M; Merz F; Rahim H; Sedlmayer F; Kogelnik HD
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):333-41. PubMed ID: 10760428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roentgenographically occult lung cancer. A ten-year experience.
    Cortese DA; Pairolero PC; Bergstralh EJ; Woolner LB; Uhlenhopp MA; Piehler JM; Sanderson DR; Bernatz PE; Williams DE; Taylor WF; Payne WS; Fontana RS
    J Thorac Cardiovasc Surg; 1983 Sep; 86(3):373-80. PubMed ID: 6350725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative radiotherapy for lung cancer: improvement in locoregional control using three-dimensional compared with two-dimensional technique.
    Masson-Côté L; Couture C; Fortin A; Dagnault A
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):686-91. PubMed ID: 20646845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose escalation of radical radiation therapy in non-small-cell lung cancer using positron emission tomography/computed tomography-defined target volumes: are class solutions obsolete?
    Everitt S; Schneider-Kolsky M; Yuen K; Budd R; Mac Manus M
    J Med Imaging Radiat Oncol; 2008 Apr; 52(2):168-77. PubMed ID: 18373810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung cancer detection with low-dose spiral computed tomography in chronic obstructive pulmonary disease patients.
    Cilli A; Ozkaynak C; Onur R; Erogullari I; Ogus C; Cubuk M; Arslan G; Ozdemir T
    Acta Radiol; 2007 May; 48(4):405-11. PubMed ID: 17453521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy.
    Anscher MS; Marks LB; Shafman TD; Clough R; Huang H; Tisch A; Munley M; Herndon JE; Garst J; Crawford J; Jirtle RL
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):988-95. PubMed ID: 12829134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy.
    Sutedja TG; Codrington H; Risse EK; Breuer RH; van Mourik JC; Golding RP; Postmus PE
    Chest; 2001 Oct; 120(4):1327-32. PubMed ID: 11591578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial.
    Westover KD; Loo BW; Gerber DE; Iyengar P; Choy H; Diehn M; Hughes R; Schiller J; Dowell J; Wardak Z; Sher D; Christie A; Xie XJ; Corona I; Sharma A; Wadsworth ME; Timmerman R
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):72-81. PubMed ID: 26279026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualized margins in 3D conformal radiotherapy planning for lung cancer: analysis of physiological movements and their dosimetric impacts.
    Germain F; Beaulieu L; Fortin A
    Med Dosim; 2008; 33(1):48-54. PubMed ID: 18262123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematoporphyrin derivative in the detection and localization of radiographically occult lung cancer.
    Cortese DA; Kinsey JH; Woolner LB; Sanderson DR; Fontana RS
    Am Rev Respir Dis; 1982 Dec; 126(6):1087-8. PubMed ID: 7181227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial.
    Wu KL; Jiang GL; Liao Y; Qian H; Wang LJ; Fu XL; Zhao S
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1336-44. PubMed ID: 14630271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.